AR043622A1 - "2- (BUTIL-1 SULFONYLAMINE) - N- [1 (R) - (6 - METOXIPIRIDIN - 3 - IL - PROPIL] BENZAMIDA, ITS USE AS A MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATIONS THAT INCLUDE IT - Google Patents
"2- (BUTIL-1 SULFONYLAMINE) - N- [1 (R) - (6 - METOXIPIRIDIN - 3 - IL - PROPIL] BENZAMIDA, ITS USE AS A MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATIONS THAT INCLUDE ITInfo
- Publication number
- AR043622A1 AR043622A1 ARP040100866A ARP040100866A AR043622A1 AR 043622 A1 AR043622 A1 AR 043622A1 AR P040100866 A ARP040100866 A AR P040100866A AR P040100866 A ARP040100866 A AR P040100866A AR 043622 A1 AR043622 A1 AR 043622A1
- Authority
- AR
- Argentina
- Prior art keywords
- metoxipiridin
- benzamida
- propil
- butil
- sulfonylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Se refiere a la 2-(butil-1-sulfonilamino)-N-[1(R)-(6-metoxipiridin-3-il)propil]-benzamida de fórmula (1), y a sus sales farmacéuticamente aceptables, a su preparación y uso, en particular para el tratamiento y profilaxis de arritmias auriculares, por ejemplo fibrilación auricular o aleteos auriculares.It refers to 2- (butyl-1-sulfonylamino) -N- [1 (R) - (6-methoxypyridin-3-yl) propyl] -benzamide of formula (1), and its pharmaceutically acceptable salts, to its preparation and use, in particular for the treatment and prophylaxis of atrial arrhythmias, for example atrial fibrillation or atrial flutters.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10312073A DE10312073A1 (en) | 2003-03-18 | 2003-03-18 | 2- (Butyl-1-sulfonylamino) -N- [1 (R) - (6-methoxypyridin-3yl) -propyl] -benzamide, its use as a medicament and pharmaceutical compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043622A1 true AR043622A1 (en) | 2005-08-03 |
Family
ID=32920928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100866A AR043622A1 (en) | 2003-03-18 | 2004-03-16 | "2- (BUTIL-1 SULFONYLAMINE) - N- [1 (R) - (6 - METOXIPIRIDIN - 3 - IL - PROPIL] BENZAMIDA, ITS USE AS A MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATIONS THAT INCLUDE IT |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1606237A1 (en) |
| JP (1) | JP2006520343A (en) |
| KR (1) | KR20050110681A (en) |
| CN (1) | CN100361943C (en) |
| AR (1) | AR043622A1 (en) |
| AU (1) | AU2004222137A1 (en) |
| BR (1) | BRPI0408441A (en) |
| CA (1) | CA2519022A1 (en) |
| DE (1) | DE10312073A1 (en) |
| HK (1) | HK1086819A1 (en) |
| HR (1) | HRP20050815A2 (en) |
| MA (1) | MA27749A1 (en) |
| MX (1) | MXPA05009763A (en) |
| MY (1) | MY176510A (en) |
| NO (1) | NO20054472L (en) |
| NZ (1) | NZ542476A (en) |
| PE (1) | PE20050307A1 (en) |
| RS (1) | RS20050690A (en) |
| RU (1) | RU2333202C2 (en) |
| TW (1) | TW200500342A (en) |
| WO (1) | WO2004083157A1 (en) |
| ZA (1) | ZA200506328B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009931A1 (en) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Use of specific 2-substituted benzamides for treating and preventing cardiac insufficiency, especially where caused by diastolic dysfunction, act by inhibition of the Kv1.5 potassium channel |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102005028845A1 (en) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | New substituted pyrrolidin-2-ones, piperidin-2-ones and isothiazolidine-1,1-dioxides useful for treating e.g. dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, breast cancer and heart failure |
| CA2615440A1 (en) * | 2005-07-22 | 2007-02-08 | Merck & Co., Inc. | Potassium channel inhibitors |
| EP3632899A1 (en) * | 2009-05-29 | 2020-04-08 | RaQualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10121003A1 (en) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/en not_active Withdrawn
-
2004
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/en not_active IP Right Cessation
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/en not_active Application Discontinuation
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/en not_active IP Right Cessation
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/en not_active Expired - Fee Related
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/en not_active Abandoned
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/en active IP Right Grant
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/en active Application Filing
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/en unknown
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/en not_active Application Discontinuation
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 EP EP04717628A patent/EP1606237A1/en not_active Withdrawn
- 2004-03-16 AR ARP040100866A patent/AR043622A1/en unknown
- 2004-03-16 TW TW093106899A patent/TW200500342A/en unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/en not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/en unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/en not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1756728A (en) | 2006-04-05 |
| ZA200506328B (en) | 2006-04-26 |
| JP2006520343A (en) | 2006-09-07 |
| EP1606237A1 (en) | 2005-12-21 |
| CA2519022A1 (en) | 2004-09-30 |
| CN100361943C (en) | 2008-01-16 |
| NZ542476A (en) | 2008-05-30 |
| HK1086819A1 (en) | 2006-09-29 |
| MXPA05009763A (en) | 2006-01-27 |
| BRPI0408441A (en) | 2006-04-04 |
| HRP20050815A2 (en) | 2006-09-30 |
| NO20054472L (en) | 2005-09-27 |
| RU2005132163A (en) | 2006-04-10 |
| MY176510A (en) | 2020-08-12 |
| KR20050110681A (en) | 2005-11-23 |
| PE20050307A1 (en) | 2005-06-08 |
| RU2333202C2 (en) | 2008-09-10 |
| AU2004222137A1 (en) | 2004-09-30 |
| MA27749A1 (en) | 2006-02-01 |
| DE10312073A1 (en) | 2004-09-30 |
| TW200500342A (en) | 2005-01-01 |
| WO2004083157A1 (en) | 2004-09-30 |
| RS20050690A (en) | 2008-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR031430A1 (en) | ORIS BISARILO COMPOUNDS, META-SUBSTITUTES, PROCEDURES FOR THEIR PREPARATION, ITS USE AS A MEDICINAL PRODUCT AS ALSO THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| BR0111206A (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
| BRPI0113146B8 (en) | "proline derivatives and pharmaceutical composition comprising them". | |
| ECSP034774A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
| ECSP034773A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
| BRPI0108395B8 (en) | pyrrolopyrimidinone derivatives, preparation and use processes | |
| PA8547701A1 (en) | NUCLEOSIDS 4 SUBSTITUTED. | |
| UY28510A1 (en) | CHEMICAL COMPOUNDS | |
| AR055076A1 (en) | 1,1-DIOXIDE DERIVATIVES OF 1,4-BENZOTIAZEPIN, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN THERAPEUTICS. | |
| BRPI0418251B8 (en) | phosphonates, monophosphonamidates, bisphosphonamidates, and pharmaceutical composition comprising them | |
| ECSP055853A (en) | NEW DERIVATIVES OF HETEROCICLIC FLUOROGLYCOSIDS, PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME | |
| DK2314582T3 (en) | Heterocyclic compounds as antiviral agents | |
| GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| BR0210711A (en) | Use of a compound, pharmaceutical composition, compound, and process for preparing a compound | |
| BR0308429A (en) | Monocyclic Aroylpyridinones as Anti-Inflammatory Agents | |
| BR0214243A (en) | Sulfonamide derivative Process for the preparation of a sulfonamide derivative and its physiologically acceptable salts, pharmaceutical composition and use of a sulfonamide derivative | |
| BRPI0412291A (en) | nka / nk3 dual antagonists for the treatment of schizophrenia | |
| BRPI0411891A (en) | pyrazol [3,4-b] pyridin-6-ones as gsk-3 inhibitors | |
| ES2421948T3 (en) | Compounds and compositions for delivering active agents | |
| BRPI0607214B8 (en) | hiv inhibitors 2-(4-cyanophenylamino)pyrimidine derivatives, pharmaceutical composition comprising them and their preparation processes | |
| BR0314195A (en) | Substituted Pyridine Derivatives as Antitumor Agents | |
| BR0307588A (en) | Compound, gsk-3 inhibitor, pharmaceutical composition, and therapeutic or preventative agent for a disease | |
| ES2163735T3 (en) | HETEROCICLIC BIARILE COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM AND USES. | |
| GT200800066A (en) | DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT. | |
| BR0103048A (en) | N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |